Endo launches two late-stage studies of CCH for the treatment of cellulite – Seeking Alpha


Philadelphia Business Journal

Endo launches two late-stage studies of CCH for the treatment of cellulite
Seeking Alpha
Endo International (NASDAQ:ENDP) initiates two identical Phase 3 studies evaluating collagenase clostridium histolyticum (CCH) for the treatment of cellulite. The trials, both called RELEASE, will enroll 840 adult women (420 in each) with moderate-to
Endo begins late-stage testing of potential cellulite treatmentPhiladelphia Business Journal
Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The …PR Newswire (press release)

all 3 news articles »

Read more: seekingalpha.com

About the Author AdelinaDuh

Leave a Comment: